Sientra, Inc. (SIEN)

NASDAQ: SIEN · IEX Real-Time Price · USD
0.500
-0.023 (-4.38%)
Sep 27, 2022 3:59 PM EDT - Market closed
-4.38%
Market Cap 31.39M
Revenue (ttm) 85.18M
Net Income (ttm) -24.00M
Shares Out 62.77M
EPS (ttm) -0.44
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 890,162
Open 0.518
Previous Close 0.523
Day's Range 0.486 - 0.576
52-Week Range 0.486 - 6.140
Beta 1.95
Analysts Buy
Price Target 3.23 (+546.0%)
Earnings Date Nov 8, 2022

About SIEN

Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surg... [Read more...]

Industry Health Care Equipment & Supplies
IPO Date Oct 29, 2014
CEO Jeffrey Nugent
Employees 319
Stock Exchange NASDAQ
Ticker Symbol SIEN
Full Company Profile

Financial Performance

In 2021, Sientra's revenue was $80.68 million, an increase of 46.70% compared to the previous year's $55.00 million. Losses were -$62.48 million, -30.53% less than in 2020.

Financial Statements

Analyst Forecast

According to 13 analysts, the average rating for SIEN stock is "Buy." The 12-month stock price forecast is 3.23, which is an increase of 546.00% from the latest price.

Price Target
$3.23
(546.00% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Sientra Receives Regulatory Approval to Market Breast Implants in Saudi Arabia

Saudi Food & Drug Authority approval propels Sientra international expansion into the GCC and Middle East region Saudi Food & Drug Authority approval propels Sientra international expansion into the GCC...

1 week ago - GlobeNewsWire

Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

SANTA BARBARA, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced tha...

2 weeks ago - GlobeNewsWire

7 Stocks Due for a Stunning Short Squeeze

Although the general rule of thumb is to avoid equities with heavy short interest, the new normal has brought with it new paradigms. One of these fresh approaches urges speculators to acquire short-sque...

Other symbols: LMNDMVISSANASTOKTTCFWE
1 month ago - InvestorPlace

Sientra to Report Second Quarter 2022 Financial Results on August 11, 2022

SANTA BARBARA, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plasti...

1 month ago - GlobeNewsWire

Sientra Wins Premier's Horizon Award for 2022 for Exceptional Customer Service, Engagement, and Value Creation

SANTA BARBARA, Calif., July 11, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a leading medical aesthetics company focused on enhancing lives by advancing the art o...

2 months ago - GlobeNewsWire

FDA Approves Sientra's Low Plus Profile Projection Breast Implant

New Implant Offers Surgeons and Their Patients More Options to Customize Their Surgical Outcomes New Implant Offers Surgeons and Their Patients More Options to Customize Their Surgical Outcomes

2 months ago - GlobeNewsWire

Sientra To Participate At The 19th Annual Craig-Hallum Institutional Investor Conference

SANTA BARBARA, Calif., May 18, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), announced today its participation at the Virtual 19 th Annual Craig-Hallum Institutiona...

4 months ago - GlobeNewsWire

Sientra (SIEN) Reports Q1 Loss, Tops Revenue Estimates

Sientra (SIEN) delivered earnings and revenue surprises of -11.54% and 5.67%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

Sientra to Report First Quarter 2022 Financial Results on May 12, 2022

SANTA BARBARA, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic...

4 months ago - GlobeNewsWire

Sientra to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on Mar...

SANTA BARBARA, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plast...

6 months ago - GlobeNewsWire

See Why Did Stifel, Maxim Cut Price Target On Sientra After Q4 Earnings

Maxim lowered the price target on Sientra Inc (NASDAQ: SIEN) to $7 from $13 but kept a Buy rating on the stock.  Analyst Anthony Vendetti notes that the Company's Q4 revenue was in-line with its pre-ann...

6 months ago - Benzinga

Sientra (SIEN) Reports Q4 Loss, Tops Revenue Estimates

Sientra (SIEN) delivered earnings and revenue surprises of -42.11% and 0.66%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Sientra Reports Record Plastic Surgery Revenue for Both Fourth Quarter and Full Year 2021

Sixth Consecutive Quarter of Record Growth

6 months ago - GlobeNewsWire

Is a Surprise Coming for Sientra (SIEN) This Earnings Season?

Sientra (SIEN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

6 months ago - Zacks Investment Research

Sientra to Report Fourth Quarter and Full Year 2021 Financial Results on March 23, 2022

SANTA BARBARA, Calif., March 09, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plast...

6 months ago - GlobeNewsWire

Sientra to Present at the H.C. Wainwright Bioconnect Virtual Conference

SANTA BARBARA, Calif., Dec. 27, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plasti...

9 months ago - GlobeNewsWire

Sientra Selects Leading Distributors for Two Key International Markets In Preparation for Further Expansion and Growt...

SANTA BARBARA, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plasti...

9 months ago - GlobeNewsWire

Sientra (SIEN) Reports Q3 Loss, Tops Revenue Estimates

Sientra (SIEN) delivered earnings and revenue surprises of -153.85% and 8.40%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

10 months ago - Zacks Investment Research

Sientra Reports Record Third Quarter 2021 Revenue for Continuing Operations

Revenue growth of 28% Year Over Year Revenue growth of 28% Year Over Year

10 months ago - GlobeNewsWire

Will Sientra (SIEN) Report Negative Earnings Next Week? What You Should Know

Sientra (SIEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

10 months ago - Zacks Investment Research

Sientra to Participate in Upcoming Investor Conferences

SANTA BARBARA, Calif., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced tha...

10 months ago - GlobeNewsWire

FDA Restricts Sale, Approves New Labeling Of Breast Implants

The FDA is restricting the sale and distribution of breast implants over concerns about the risks of the devices, limiting the products to healthcare providers and facilities that provide information us...

Other symbols: ABBVJNJ
10 months ago - Benzinga

Sientra to Report Third Quarter 2021 Financial Results on Wednesday, November 10, 2021

SANTA BARBARA, Calif., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced tha...

11 months ago - GlobeNewsWire

Sientra® And Mission Plasticos Launch Reshaping Lives: Full Circle™ A Philanthropic Initiative For Women Living In Po...

Reshaping Lives: Full Circle will provide post-mastectomy reconstructive breast surgery to women in need of assistance

11 months ago - GlobeNewsWire

New Study Confirms Sientra's AlloX2's Unique Value in Managing Seroma and Infection Post Reconstruction Procedures

SANTA BARBARA, Calif., Aug. 25, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgery, today announced that...

1 year ago - GlobeNewsWire